Company
RECURSION PHARMACEUTICALS, INC.
RXRX · CIK 0001601830
Disposition (code F) of 5,396 shares at $3.41 per share.
Reporting Person Taylor Ben R · Officer Title Chief Financial Officer · Transaction Code F
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001601830-26-000110 · filed 2026-09-16 · View filing →
Sale of 22,408 shares at $3.5176 per share.
Reporting Person Khan Najat · Officer Title CEO and President · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001601830-26-000105 · filed 2026-09-10 · View filing →
Sale of 30,000 shares at $3.34 per share.
Reporting Person Borgeson Blake · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001601830-26-000103 · filed 2026-09-02 · View filing →
Disposition (code F) of 25,018 shares at $3.16 per share.
Reporting Person Taylor Ben R · Officer Title Chief Financial Officer · Transaction Code F
Traded Aug 17, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001712276-26-000009 · filed 2026-08-18 · View filing →
Disposition (code F) of 26,657 shares at $3.16 per share.
Reporting Person Hallett David · Officer Title Chief Scientific Officer · Transaction Code F
Traded Aug 17, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0002006495-26-000012 · filed 2026-08-18 · View filing →
Disposition (code F) of 80,498 shares at $3.16 per share.
Reporting Person Khan Najat · Officer Title CEO and President · Transaction Code F
Traded Aug 17, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0002020969-26-000006 · filed 2026-08-18 · View filing →